During the past decade, CH de Bastia conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Bastia" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "ZIWIG" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored, "Biotronik France" with 1 trials sponsored and "Biotronik SE & Co. KG" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Bastia" #1 collaborator was "Monitoring Force Group" with 2 trials as a collaborator, "iGenSeq" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "CH de Bastia" are "Breast Cancer" (2 trials), "Coronary Artery Disease" (2 trials), "Angioplasty" (1 trials), "Borderline Ovarian Cancer" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "CH de Bastia" in a lesser frequency.

Most popular intervention types in "CH de Bastia" are "Other" (4 trials), "Procedure" (4 trials), "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Drug Eluting Stent (DES)" (1 trials), "Dual-agent therapy or docetaxel alone or best supportive care" (1 trials), "Family members of patients admitted to the ICU" (1 trials), "Health care professionals" (1 trials) and "Immediate Stenting (one-step strategy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de Bastia" are 12 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CH de Bastia". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CH de Bastia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CH de Bastia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".